AGENUS INC. Common Stock (par value 0.01) AT MARKET ISSUANCE SALES AGREEMENTSales Agreement • March 2nd, 2012 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 2nd, 2012 Company Industry JurisdictionAgenus Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV” or the “Agent”), as follows: